Published in Mol Imaging Biol on December 01, 2009
Development and evaluation of a novel (99m)tc-labeled annexin A5 for early detection of response to chemotherapy. PLoS One (2013) 0.84
In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery. Eur J Nucl Med Mol Imaging (2014) 0.82
Radiotracers used for the scintigraphic detection of infection and inflammation. ScientificWorldJournal (2015) 0.80
Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation. Eur J Nucl Med Mol Imaging (2012) 0.78
Tracking and treating activated T cells. J Drug Deliv Sci Technol (2013) 0.78
Interleukin-2: inception, impact, and implications. Science (1988) 8.19
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med (1990) 1.92
The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases. Nucl Med Biol (1997) 0.91
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging (2003) 0.89
99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study. J Nucl Med (2004) 0.86
Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet. Eur J Nucl Med (2000) 0.85
I-interleukin-2 scintigraphy: a new approach to assess disease activity in autoimmunity. J Pediatr Endocrinol Metab (1996) 0.83
Immunomodulatory effects of rexinoids. Semin Oncol (2006) 0.83
The developing role of peptide radiopharmaceuticals in the study of chronic inflammation: new techniques for novel therapeutic options. Q J Nucl Med (2003) 0.82
(123)I-Interleukin-2 uptake in squamous cell carcinoma of the head and neck carcinoma. Eur J Nucl Med Mol Imaging (2007) 0.82
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med (2004) 2.22
Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med (2009) 2.17
A large retrospective single-centre study to define the best image acquisition protocols and interpretation criteria for white blood cell scintigraphy with ⁹⁹mTc-HMPAO-labelled leucocytes in musculoskeletal infections. Eur J Nucl Med Mol Imaging (2013) 2.04
Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol (2011) 1.65
Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol (2014) 1.55
99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging (2005) 1.51
Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat Mater (2010) 1.45
[11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Mol Imaging Biol (2009) 1.43
90Y PET-based dosimetry after selective internal radiotherapy treatments. Nucl Med Commun (2012) 1.42
EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med (2013) 1.37
Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2010) 1.27
Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor. J Immunol (2008) 1.27
99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells. Eur J Nucl Med Mol Imaging (2011) 1.26
An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors. J Nucl Med (2003) 1.18
The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol (2013) 1.13
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther (2002) 1.11
PET imaging of oestrogen receptors in patients with breast cancer. Lancet Oncol (2013) 1.10
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. Eur J Nucl Med Mol Imaging (2014) 1.10
PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma. J Nucl Med (2012) 1.10
Comment on Aksoy et al.: FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection. Eur J Nucl Med Mol Imaging (2014) 1.09
PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? Eur J Nucl Med Mol Imaging (2012) 1.08
Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. J Clin Oncol (2003) 1.07
Time for radiobiology in the nuclear medicine community. Eur J Nucl Med Mol Imaging (2011) 1.07
Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis (2010) 1.05
PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. Curr Pharm Des (2008) 1.04
FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging (2010) 1.03
Contrasting effects of sunitinib within in vivo models of metastasis. Angiogenesis (2012) 1.00
Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun (2006) 0.98
Imaging of β-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus. Endocr Rev (2012) 0.98
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med (2012) 0.98
Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide. J Nucl Med (2009) 0.98
Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2010) 0.98
CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid (2005) 0.97
Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes. Nat Protoc (2006) 0.96
Leukocyte and bacteria imaging in prosthetic joint infection. Eur Cell Mater (2013) 0.96
New frontiers of MRI in Crohn's disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI). Abdom Imaging (2012) 0.96
Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. Arthritis Rheum (2005) 0.95
Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time. Clin Nucl Med (2009) 0.95
Nuclear medicine imaging of bone infections. Nucl Med Commun (2006) 0.93
In vivo biodistribution of stem cells using molecular nuclear medicine imaging. J Cell Physiol (2011) 0.93
Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res (2009) 0.93
Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res (2009) 0.92
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J Alzheimers Dis (2012) 0.92
[18F]FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin. Mol Imaging (2012) 0.92
Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation. J Med Chem (2009) 0.91
18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers. Nucl Med Commun (2006) 0.90
Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med (2011) 0.90
Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes. Nat Protoc (2006) 0.89
99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging (2003) 0.89
90Y-PET for the assessment of microsphere biodistribution after selective internal radiotherapy. Nucl Med Commun (2012) 0.89
Tumour angiogenesis pathways: related clinical issues and implications for nuclear medicine imaging. Eur J Nucl Med Mol Imaging (2002) 0.89
How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies. Dalton Trans (2007) 0.88
Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry. Ann Nucl Med (2013) 0.87
Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun (2005) 0.87
Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid (2011) 0.87
Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy. Leuk Lymphoma (2011) 0.86
Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging (2007) 0.86
Imaging of cell trafficking in Crohn's disease. J Cell Physiol (2010) 0.86
High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6. J Pathol (2010) 0.86
99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study. J Nucl Med (2004) 0.86
188Re(CO)3-dipicolylamine-alendronate: a new bisphosphonate conjugate for the radiotherapy of bone metastases. Bioconjug Chem (2010) 0.86
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma. Cancer Biother Radiopharm (2004) 0.86
Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids. J Inorg Biochem (2009) 0.86
Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors. J Nucl Med (2003) 0.85
Image acquisition and interpretation criteria for 99mTc-HMPAO-labelled white blood cell scintigraphy: results of a multicentre study. Eur J Nucl Med Mol Imaging (2013) 0.85
Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis. Nucl Med Biol (2009) 0.85
Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck. Cancer Biother Radiopharm (2008) 0.85
Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells. Mol Med (2012) 0.84
Slow coronary flow and stress myocardial perfusion imaging. Different patterns in acute patients. J Cardiovasc Med (Hagerstown) (2006) 0.84
The human norepinephrine transporter in combination with 11C-m-hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy. J Nucl Med (2005) 0.84
Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies. Int J Mol Imaging (2011) 0.84
Gastrin-releasing peptide (GRP) analogues for cancer imaging. Cancer Biother Radiopharm (2004) 0.84
Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy. J Nucl Med (2006) 0.84
11C-hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas. J Nucl Med (2012) 0.84
N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes. J Nucl Med (2012) 0.84
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI. Eur J Nucl Med Mol Imaging (2015) 0.83
Biological therapies for rheumatoid arthritis: progress to date. BioDrugs (2013) 0.83
PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [11C]MeDAS, [11C]CIC and [11C]PIB. Eur J Nucl Med Mol Imaging (2014) 0.83
Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer. Cancer Biother Radiopharm (2004) 0.83
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma. Tumori (2005) 0.83
In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice. Mol Pharm (2012) 0.82
Biological imaging for the diagnosis of inflammatory conditions. BioDrugs (2002) 0.82